Skip to content

Clinical trials

Phase 2 Stroke trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 2 Country / region: Australia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20031
20071
20091
20121
20173
20181
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Neuroscience Trials Australia4
Astellas Pharma Inc2
Basking Biosciences, Inc.1
Bayer1
Dart NeuroScience, LLC1
Medical Benefits Fund of Australia1
Melbourne Health1
The Florey Institute of Neuroscience and Mental Health1
University of Sydney1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke13
Ischemic Stroke6
Brain Diseases3
Cardiovascular Diseases3
Central Nervous System Diseases3
Cerebrovascular Disorders3
Nervous System Diseases3
Vascular Diseases3
Atrial Fibrillation2
Cerebral Hemorrhage2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.